431 related articles for article (PubMed ID: 37548933)
1. Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia.
Deng W; Yi P; Xiong Y; Ying J; Lin Y; Dong Y; Wei G; Wang X; Hua F
Aging Dis; 2024 Apr; 15(2):480-502. PubMed ID: 37548933
[TBL] [Abstract][Full Text] [Related]
2. Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis.
Wei H; Yu C; Zhang C; Ren Y; Guo L; Wang T; Chen F; Li Y; Zhang X; Wang H; Liu J
Biomed Pharmacother; 2023 Apr; 160():114308. PubMed ID: 36709599
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation in the Brain and Role of Intestinal Microbiota: An Overview of the Players.
Cavaliere G; Traina G
J Integr Neurosci; 2023 Oct; 22(6):148. PubMed ID: 38176933
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-derived metabolites and their importance in neurological disorders.
Swer NM; Venkidesh BS; Murali TS; Mumbrekar KD
Mol Biol Rep; 2023 Feb; 50(2):1663-1675. PubMed ID: 36399245
[TBL] [Abstract][Full Text] [Related]
5. Immune-microbiome interplay and its implications in neurodegenerative disorders.
Uniyal A; Tiwari V; Rani M; Tiwari V
Metab Brain Dis; 2022 Jan; 37(1):17-37. PubMed ID: 34357554
[TBL] [Abstract][Full Text] [Related]
6. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System.
Doroszkiewicz J; Groblewska M; Mroczko B
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576191
[TBL] [Abstract][Full Text] [Related]
7. Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat.
Li H; Xiang Y; Zhu Z; Wang W; Jiang Z; Zhao M; Cheng S; Pan F; Liu D; Ho RCM; Ho CSH
J Neuroinflammation; 2021 Nov; 18(1):254. PubMed ID: 34736493
[TBL] [Abstract][Full Text] [Related]
8. Roles of Diet-Associated Gut Microbial Metabolites on Brain Health: Cell-to-Cell Interactions between Gut Bacteria and the Central Nervous System.
Kim CS
Adv Nutr; 2024 Jan; 15(1):100136. PubMed ID: 38436218
[TBL] [Abstract][Full Text] [Related]
9. The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Cross-Talk with a Focus on Amyotrophic Lateral Sclerosis: A Systematic Review.
Moțățăianu A; Șerban G; Andone S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894774
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention.
Bhuiyan P; Chen Y; Karim M; Dong H; Qian Y
Brain Res Bull; 2021 Jul; 172():61-78. PubMed ID: 33892083
[TBL] [Abstract][Full Text] [Related]
11. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
Raj K; Singh S; Chib S; Mallan S
Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
[TBL] [Abstract][Full Text] [Related]
12. Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder.
Chen CY; Wang YF; Lei L; Zhang Y
Life Sci; 2024 Aug; 351():122815. PubMed ID: 38866215
[TBL] [Abstract][Full Text] [Related]
13. Microbiome-microglia connections via the gut-brain axis.
Abdel-Haq R; Schlachetzki JCM; Glass CK; Mazmanian SK
J Exp Med; 2019 Jan; 216(1):41-59. PubMed ID: 30385457
[TBL] [Abstract][Full Text] [Related]
14. The Molecular Gut-Brain Axis in Early Brain Development.
Muhammad F; Fan B; Wang R; Ren J; Jia S; Wang L; Chen Z; Liu XA
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499716
[TBL] [Abstract][Full Text] [Related]
15. The Microbiota-Gut-Brain Axis.
Cryan JF; O'Riordan KJ; Cowan CSM; Sandhu KV; Bastiaanssen TFS; Boehme M; Codagnone MG; Cussotto S; Fulling C; Golubeva AV; Guzzetta KE; Jaggar M; Long-Smith CM; Lyte JM; Martin JA; Molinero-Perez A; Moloney G; Morelli E; Morillas E; O'Connor R; Cruz-Pereira JS; Peterson VL; Rea K; Ritz NL; Sherwin E; Spichak S; Teichman EM; van de Wouw M; Ventura-Silva AP; Wallace-Fitzsimons SE; Hyland N; Clarke G; Dinan TG
Physiol Rev; 2019 Oct; 99(4):1877-2013. PubMed ID: 31460832
[TBL] [Abstract][Full Text] [Related]
16. Overview of the Gut-Brain Axis: From Gut to Brain and Back Again.
Post Z; Manfready RA; Keshavarzian A
Semin Neurol; 2023 Aug; 43(4):506-517. PubMed ID: 37562457
[TBL] [Abstract][Full Text] [Related]
17. The interplay between gut microbiota and autism spectrum disorders: A focus on immunological pathways.
Moradi K; Ashraf-Ganjouei A; Tavolinejad H; Bagheri S; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110091. PubMed ID: 32891667
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota, Nitric Oxide, and Microglia as Prerequisites for Neurodegenerative Disorders.
Tse JKY
ACS Chem Neurosci; 2017 Jul; 8(7):1438-1447. PubMed ID: 28640632
[TBL] [Abstract][Full Text] [Related]
19. Regulation of common neurological disorders by gut microbial metabolites.
Park J; Kim CH
Exp Mol Med; 2021 Dec; 53(12):1821-1833. PubMed ID: 34857900
[TBL] [Abstract][Full Text] [Related]
20. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases.
Loh JS; Mak WQ; Tan LKS; Ng CX; Chan HH; Yeow SH; Foo JB; Ong YS; How CW; Khaw KY
Signal Transduct Target Ther; 2024 Feb; 9(1):37. PubMed ID: 38360862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
